Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about LEGN

Recent news which mentions LEGN

< Previous 1 2 3 4 5 Next >
Johnson & Johnson's Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients
Tickers JNJ LEGN NEWS
Tags Biotech Stories That Matter Market News
From Benzinga
Assessing Legend Biotech: Insights From 15 Financial Analysts
Tickers LEGN
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst
Tickers JNJ LEGN
Tags Trading Ideas Health Care Analyst Color
From Benzinga
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
Tickers ACLS AGIO HALO IRTC
Tags Stories That Matter TWST NVDA
From Benzinga
Unveiling 18 Analyst Insights On Legend Biotech
Tickers LEGN
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
Legend Biotech Stock: A Deep Dive Into Analyst Perspectives (14 Ratings)
Tickers LEGN
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
LEGN Stock Earnings: Legend Biotech Beats EPS, Misses Revenue for Q1 2024
Tickers LEGN
Tags Market News Earnings Reports LEGN
From InvestorPlace
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
Tickers BMY GILD JNJ LEGN
Tags Market News TSVT LEGN
From Benzinga
Analyst Ratings For Legend Biotech
Tickers LEGN
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population
Tickers JNJ LEGN NEWS NVS
Tags Benzinga Analyst Ratings General
From Benzinga
Unveiling 9 Analyst Insights On Legend Biotech
Tickers LEGN
Tags Benzinga LEGN BZI/AAR
From Benzinga
GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy
Tickers ASIA BMY JNJ LEGN
Tags JNJ LEGN NVS
From Benzinga
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
Tickers BMY JNJ LEGN NEWS
Tags FDA Stories That Matter Biotech
From Benzinga
FDA To Review Two Cell Therapies For Multiple Myeloma This Week - Johnson & Johnson And Bristol-Myers
Tickers BMY JNJ LEGN NEWS
Tags Health Care News Large Cap
From Benzinga
Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
Tickers BGNE CLOV HCM LEGN
Tags Top Gainers YMM BGNE
From Benzinga
Earnings Scheduled For March 11, 2024
Tickers ALTO ASAN ASRT AVO
Tags BZI/UE MTN EXK
From Benzinga
Earnings Preview: Legend Biotech
Tickers LEGN
Tags Market News BZI/EP Earnings
From Benzinga
Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley
Tickers ACLX BMY GILD JNJ
Tags News Trading Ideas Health Care
From Benzinga
What 4 Analyst Ratings Have To Say About Legend Biotech
Tickers LEGN
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
Tickers AZN BMY GILD GRCL
Tags Market News GRCL NVS
From Benzinga
As China's Population Declines In 2023, Will Aging Demographics Boost Healthcare Stocks?
Tickers ASIA BABA BGNE CHIR
Tags #ChinaSlowdown Health Care BABA
From Benzinga
Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024
Tickers ACLX JNJ LEGN NEWS
Tags Health Care Analyst Color ACLX
From Benzinga
Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback
Tickers ALNY ARWR IBB LEGN
Tags Sector ETFs IBB Expert Ideas
From Benzinga
Key Takeaways From Legend Biotech Analyst Ratings
Tickers LEGN
Tags Benzinga LEGN BZI/AAR
From Benzinga
Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say
Tickers ACLX JNJ LEGN
Tags Equities Market News Movers
From Benzinga
Bristol Myers Squibb, 2seventy bio shares fall as FDA delays action on cancer treatment
Tickers BMY JNJ LEGN SPX
Tags BMY LEGN JNJ
From MarketWatch
Earnings Scheduled For November 20, 2023
Tickers A BLRX BRBR CENT
Tags BLRX FANH POL
From Benzinga
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On
Tickers CVRX JNJ LEGN NVS
Tags Market News PTGX NVS
From Motley Fool
Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug
Tickers JNJ LEGN
Tags Market News JNJ LEGN
From Benzinga
Analyst Ratings for Legend Biotech
Tickers LEGN
Tags LEGN Benzinga Analyst Ratings
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.